At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,168 enrolled
Drug / intervention
Pioglitazone/glimepiridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey on Long-term Use for in Type 2 Diabetes Mellitus
In Brief
An observational study evaluating Pioglitazone/glimepiride for Type 2 Diabetes. Completed, enrolled 1,168 participants.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of long-term use of Sonias Combination Tablets in patients with type 2 diabetes mellitus in the routine clinical setting.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedMar 2014
Primary CompletionMay 2014
TodayJul 2026
First PostedMar 28, 2014
Enrollment StartJun 1, 2011
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.3 years ago
Interventions
Pioglitazone/glimepiridedrug
Pioglitazone/glimepiride combination tablets